| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.88B | 15.91B | 14.74B | 12.84B | 11.16B | 9.78B |
| Gross Profit | 14.06B | 14.03B | 12.59B | 11.34B | 10.75B | 9.66B |
| EBITDA | 2.84B | 4.76B | 2.82B | 2.44B | 2.17B | 1.93B |
| Net Income | 2.10B | 2.13B | 2.07B | 1.74B | 1.51B | 1.40B |
Balance Sheet | ||||||
| Total Assets | 88.76B | 88.23B | 82.99B | 78.36B | 80.95B | 61.89B |
| Cash, Cash Equivalents and Short-Term Investments | 16.53B | 18.28B | 19.25B | 18.47B | 15.99B | 15.52B |
| Total Debt | 4.59B | 4.54B | 4.03B | 3.48B | 3.79B | 3.17B |
| Total Liabilities | 76.19B | 75.73B | 71.33B | 68.17B | 71.52B | 53.59B |
| Stockholders Equity | 12.57B | 12.50B | 11.67B | 10.21B | 9.46B | 8.24B |
Cash Flow | ||||||
| Free Cash Flow | 1.55B | 2.25B | 1.95B | -3.69B | -19.00M | 6.57B |
| Operating Cash Flow | 1.75B | 2.43B | 2.15B | -3.51B | 72.00M | 6.65B |
| Investing Cash Flow | -5.40B | -4.32B | -968.00M | -274.00M | -7.15B | -5.14B |
| Financing Cash Flow | 3.44B | 2.36B | 438.00M | 1.44B | 5.88B | 5.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $30.60B | 29.11 | 19.88% | 0.46% | 11.88% | 28.96% | |
74 Outperform | $166.44B | 20.00 | 17.91% | 1.07% | 5.90% | 66.60% | |
70 Outperform | $28.75B | 14.06 | 16.94% | 1.26% | 6.45% | 5.85% | |
69 Neutral | $11.23B | 12.55 | 11.96% | 1.43% | 7.54% | 2.73% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $24.08B | 32.56 | 18.57% | 0.32% | 35.19% | -18.62% | |
56 Neutral | $8.19B | 14.25 | 6.84% | 2.52% | -5.41% | 25.28% |